PTEN function: the long and the short of it
Open accessAbstract
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a phosphatase that is frequently altered in cancer. PTEN has phosphatase-dependent and -independent roles, and genetic alterations in PTEN lead to deregulation of protein synthesis, the cell cycle, migration, growth, DNA repair, and survival signaling. PTEN localization, stability, conformation, and phosphatase activity are controlled by an array of protein-protein interactions and post-translational modifications. Thus, PTEN-interacting and -modifying proteins have profound effects on the tumor suppressive functions of PTEN. Moreover, recent studies identified mechanisms by which PTEN can exit cells, via either exosomal export or secretion, and act on neighboring cells. This review focuses on modes of PTEN protein regulation and ways in which perturbations in this regulation may lead to disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PTEN is commonly mutated in wide ranges of GBM, which may be a candidate for therapeutic intervention.
“A tumour suppressor gene, like phosphatase and tensin homologue (PTEN), is commonly mutated in wide ranges of GBM, which may be a great candidate for therapeutic intervention27,54.”
From Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system (2025) · cites this paper as [54]
The ‘Importance of PTEN function and regulation’ section (page not provided) identifies PTEN as a tumour suppressor frequently lost in cancers including brain tumours and reports mutations across many tumour types. It does not establish how commonly PTEN is mutated specifically in GBM or identify it as a therapeutic candidate for GBM. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455 · see citing works
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926 · see citing works
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748 · see citing works
MC1R Is a Potent Regulator of PTEN after UV Exposure in Melanocytes
Cao, J., Wan, L., Hacker, E., Dai, X., Lenna, S., Jimenez-Cervantes, C., Wang, Y., Leslie, N. R., Xu, G. X., Widlund, H. R., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.010 · Cited by 144 · see citing works
Flagged first, then by citations
Research works printed but not linked: 119
- [1]Li J PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer Science 1997 275 1943 1947 9072974
- [2]Steck PA Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nature genetics 1997 15 356 362 9090379
- [3]Gao J Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal Science signaling 2013 6 pl1 23550210 PMC4160307
- [5]Li DM Sun H TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta Cancer research 1997 57 2124 2129 9187108
- [6]Myers MP The lipid phosphatase activity of PTEN is critical for its tumor supressor function Proceedings of the National Academy of Sciences of the United States of America 1998 95 13513 13518 9811831 PMC24850
- [7]Maehama T Dixon JE The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate The Journal of biological chemistry 1998 273 13375 13378 9593664
- [8]Stambolic V Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 1998 95 29 39 9778245
- [9]Leslie NR PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration Current biology: CB 2007 17 115 125 17240336 PMC1885949
- [10]Raftopoulou M Regulation of cell migration by the C2 domain of the tumor suppressor PTEN Science 2004 303 1179 1181 14976311
- [11]Dey N The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration Cancer research 2008 68 1862 1871 18339867
- [12]Tamura M Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Science 1998 280 1614 1617 9616126
- [14]Cully M Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis Nature reviews. Cancer 2006 6 184 192 16453012
- [15]Mayo LD Donner DB The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network Trends in biochemical sciences 2002 27 462 467 12217521
- [16]Alimonti A Subtle variations in Pten dose determine cancer susceptibility Nature genetics 2010 42 454 458 20400965 PMC3118559
- [17]Shen-Li H Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice Cancer biology & therapy 2010 10 1194 1200 20980828 PMC3018670
- [18]Liaw D Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome Nature genetics 1997 16 64 67 9140396
- [19]Arch EM Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease American journal of medical genetics 1997 71 489 493 9286463
- [20]Zhou X Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes Lancet 2001 358 210 211 11476841
- [21]Marsh DJ Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation Genes, chromosomes & cancer 1998 21 61 69 9443042
- [22]Zhou XP Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults American journal of human genetics 2003 73 1191 1198 14566704 PMC1180498
- [23]Butler MG Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations Journal of medical genetics 2005 42 318 321 15805158 PMC1736032
- [24]Hollander MC PTEN loss in the continuum of common cancers, rare syndromes and mouse models Nature reviews. Cancer 2011 11 289 301 PMC6946181 21430697
- [25]Trimboli AJ Pten in stromal fibroblasts suppresses mammary epithelial tumours Nature 2009 461 1084 1091 19847259 PMC2767301
- [26]Tibarewal P PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity Science signaling 2012 5 ra18 22375056
- [27]Lee JO Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association Cell 1999 99 323 334 10555148
- [28]Walker SM The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif The Biochemical journal 2004 379 301 307 14711368 PMC1224073
- [29]Campbell RB Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate The Journal of biological chemistry 2003 278 33617 33620 12857747
- [30]Vazquez F Phosphorylation of the PTEN tail regulates protein stability and function Molecular and cellular biology 2000 20 5010 5018 10866658 PMC85951
- [31]Lee SR Reversible inactivation of the tumor suppressor PTEN by H2O2 The Journal of biological chemistry 2002 277 20336 20342 11916965
- [32]Silva A PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability The Journal of clinical investigation 2008 118 3762 3774 18830414 PMC2556239
- [33]Okumura K PCAF modulates PTEN activity The Journal of biological chemistry 2006 281 26562 26568 16829519
- [34]Ikenoue T PTEN acetylation modulates its interaction with PDZ domain Cancer research 2008 68 6908 6912 18757404
- [35]Wang X NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN Cell 2007 128 129 139 17218260 PMC1828909
- [37]Fouladkou F The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization Proceedings of the National Academy of Sciences of the United States of America 2008 105 8585 8590 18562292 PMC2438405
- [38]Drinjakovic J E3 ligase Nedd4 promotes axon branching by downregulating PTEN Neuron 2010 65 341 357 20159448 PMC2862300
- [39]Van Themsche C X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization The Journal of biological chemistry 2009 284 20462 20466 19473982 PMC2742810
- [40]Maddika S WWP2 is an E3 ubiquitin ligase for PTEN Nature cell biology 2011 13 728 733 PMC3926303 21532586
- [41]Lee JT RFP-mediated ubiquitination of PTEN modulates its effect on AKT activation Cell research 2013 23 552 564 23419514 PMC3616435
- [42]Maccario H Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress The Journal of biological chemistry 2010 285 12620 12628 20177066 PMC2857106
- [43]Huang J SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane Nature communications 2012 3 911 22713753
- [44]Bassi C Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress Science 2013 341 395 399 23888040 PMC5087104
- [45]Miller SJ Direct identification of PTEN phosphorylation sites FEBS letters 2002 528 145 153 12297295
- [46]Torres J Pulido R The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation The Journal of biological chemistry 2001 276 993 998 11035045
- [47]Al-Khouri AM Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta The Journal of biological chemistry 2005 280 35195 35202 16107342
- [48]Koul D Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity Oncogene 2002 21 2357 2364 11948419
- [49]Lu Y Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades The Journal of biological chemistry 2003 278 40057 40066 12869565
- [50]Li Z Regulation of PTEN by Rho small GTPases Nature cell biology 2005 7 399 404 15793569
- [51]Yim EK Rak functions as a tumor suppressor by regulating PTEN protein stability and function Cancer cell 2009 15 304 314 19345329 PMC2673492
- [52]Maccario H PTEN is destabilized by phosphorylation on Thr366 The Biochemical journal 2007 405 439 444 17444818 PMC2267318
- [53]Odriozola L Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain The Journal of biological chemistry 2007 282 23306 23315 17565999
- [54]Zhang XC Functional analysis of the protein phosphatase activity of PTEN The Biochemical journal 2012 444 457 464 22413754 PMC3365644
- [55]Rahdar M A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN Proceedings of the National Academy of Sciences of the United States of America 2009 106 480 485 19114656 PMC2626728
- [56]Tolkacheva T Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383 Cancer research 2001 61 4985 4989 11431330
- [57]Vazquez F Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex The Journal of biological chemistry 2001 276 48627 48630 11707428
- [58]Okumura K Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor Proceedings of the National Academy of Sciences of the United States of America 2005 102 2703 2706 15659546 PMC549467
- [59]Torres J Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions The Journal of biological chemistry 2003 278 30652 30660 12788938
- [60]Ning K A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic beta-cells The EMBO journal 2006 25 2377 2387 16675953 PMC1478173
- [61]Moult PR Leptin regulates AMPA receptor trafficking via PTEN inhibition The Journal of neuroscience: the official journal of the Society for Neuroscience 2010 30 4088 4101 20237279 PMC2843829
- [62]Patsoukis N PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2 Molecular and cellular biology 2013 33 3091 3098 23732914 PMC3753920
- [63]Yang Z Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: a novel mechanism of PTEN inactivation Clinics and research in hepatology and gastroenterology 2013 37 72 79 22521126
- [64]Vo K Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation Molecular cancer 2011 10 138 22074495 PMC3253061
- [66]Lima-Fernandes E Distinct functional outputs of PTEN signalling are controlled by dynamic association with beta-arrestins The EMBO journal 2011 30 2557 2568 21642958 PMC3155309
- [67]Wu X Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2 Proceedings of the National Academy of Sciences of the United States of America 2000 97 4233 4238 10760291 PMC18208
- [68]Wu Y Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase The Journal of biological chemistry 2000 275 21477 21485 10748157
- [69]Kotelevets L Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2005 19 115 117 15629897
- [70]Takahashi Y PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling The EMBO journal 2006 25 910 920 16456542 PMC1383560
- [71]Chagpar RB Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase Proceedings of the National Academy of Sciences of the United States of America 2010 107 5471 5476 20212113 PMC2851819
- [72]Cheung LW High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability Cancer discovery 2011 1 170 185 21984976 PMC3187555
- [73]Sumitomo M Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN Cancer cell 2004 5 67 78 14749127
- [74]Fine B Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a Science 2009 325 1261 1265 19729658 PMC2936784
- [75]Hodakoski C Regulation of PTEN Inhibition by the pleckstrin homology domain of PREX2 during insulin signaling and glucose homeostasis Proceedings of the National Academy of Sciences of the United States of America 2014 IN PRESS PMC3890808 24367090
- [76]Berger MF Melanoma genome sequencing reveals frequent PREX2 mutations Nature 2012 485 502 506 22622578 PMC3367798
- [77]Ikeda F SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis Nature 2011 471 637 641 21455181 PMC3085511
- [78]He L Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells The Journal of clinical investigation 2010 120 2094 2108 20458142 PMC2877943
- [79]Wang L Suzuki T Dual functions for cytosolic alpha-mannosidase (Man2C1): its down-regulation causes mitochondria-dependent apoptosis independently of its alpha-mannosidase activity The Journal of biological chemistry 2013 288 11887 11896 23486476 PMC3636876
- [80]Yue W Suppression of 6A8 alpha-mannosidase gene expression reduced the potentiality of growth and metastasis of human nasopharyngeal carcinoma International journal of cancer. Journal international du cancer 2004 108 189 195 14639601
- [81]Tian Y Inhibition of alpha-mannosidase Man2c1 gene expression suppresses growth of esophageal carcinoma cells through mitotic arrest and apoptosis Cancer science 2008 99 2428 2434 19018777 PMC11158925
- [82]Xiang ZG hMan2c1 transgene promotes tumor progress in mice Transgenic research 2010 19 67 75 19572206
- [83]He L alpha-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells Nature communications 2011 2 307 21556061
- [84]Song MS Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner Cell 2011 144 187 199 21241890 PMC3249980
- [85]Putz U The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells Science signaling 2012 5 ra70 23012657
- [86]Hopkins BD A secreted PTEN phosphatase that enters cells to alter signaling and survival Science 2013 341 399 402 23744781 PMC3935617
- [87]Malaney P The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy Molecular bioSystems 2013 9 2877 2888 24056727
- [88]Mistafa O Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases The Journal of biological chemistry 2010 285 27900 27910 20605778 PMC2934657
- [89]Lin HK Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells Mol Endocrinol 2004 18 2409 2423 15205473
- [90]Fan C PTEN inhibits BMI1 function independently of its phosphatase activity Molecular cancer 2009 8 98 19903340 PMC2777864
- [91]Crockett DK Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics Proteomics 2005 5 1250 1262 15717329
- [92]Caselli A Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1 Biochemical and biophysical research communications 2002 296 692 697 12176037
- [93]Shen WH Essential role for nuclear PTEN in maintaining chromosomal integrity Cell 2007 128 157 170 17218262
- [94]Sotelo NS A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains Journal of cellular biochemistry 2012 113 2661 2670 22434720
- [95]Adey NB Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding Cancer research 2000 60 35 37 10646847
- [96]Lu D Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression Gastroenterology 2011 140 2084 2094 21354147 PMC3109169
- [97]Gorbenko O Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4 Molecular and cellular biochemistry 2010 337 299 305 19911253
- [98]Yang C PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha Molecular cancer 2013 12 21 23514585 PMC3610140
- [99]Okahara F Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein The Journal of biological chemistry 2004 279 45300 45303 15355975
- [100]Jurado S PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression The EMBO journal 2010 29 2827 2840 20628354 PMC2924645
- [101]Gunaratne J Protein interactions of phosphatase and tensin homologue (PTEN) and its cancer-associated G20E mutant compared by using stable isotope labeling by amino acids in cell culture-based parallel affinity purification The Journal of biological chemistry 2011 286 18093 18103 21454687 PMC3093882
- [102]Valiente M Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases The Journal of biological chemistry 2005 280 28936 28943 15951562
- [103]Lin MC PTEN interacts with metal-responsive transcription factor 1 and stimulates its transcriptional activity The Biochemical journal 2012 441 367 377 21883094
- [104]Yu Z PTEN associates with the vault particles in HeLa cells The Journal of biological chemistry 2002 277 40247 40252 12177006
- [105]van Diepen MT MyosinV controls PTEN function and neuronal cell size Nature cell biology 2009 11 1191 1196 PMC2756284 19767745
- [106]Howitt J Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia The Journal of cell biology 2012 196 29 36 22213801 PMC3255971
- [107]Mund T Pelham HR Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2 Proceedings of the National Academy of Sciences of the United States of America 2010 107 11429 11434 20534535 PMC2895104
- [108]von Stein W Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling Development 2005 132 1675 1686 15743877
- [109]Mahimainathan L Choudhury GG Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase The Journal of biological chemistry 2004 279 15258 15268 14718524
- [110]Cao J Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity The EMBO journal 2009 28 1505 1517 19369943 PMC2688529
- [111]Haier J Nicolson GL PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow Oncogene 2002 21 1450 1460 11857088
- [112]Tamura M PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway The Journal of biological chemistry 1999 274 20693 20703 10400703
- [113]Kim YJ PTEN modulates miR-21 processing via RNA-regulatory protein RNH1 PloS one 2011 6 e28308 22162762 PMC3230587
- [114]Sanchez T PTEN as an effector in the signaling of antimigratory G protein-coupled receptor Proceedings of the National Academy of Sciences of the United States of America 2005 102 4312 4317 15764699 PMC555509
- [115]Yang L Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression Endocrinology 2011 152 4537 4549 21990315
- [116]Hjelmeland AB Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity Cancer research 2005 65 11276 11281 16357132
- [117]Mehenni H LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes Human molecular genetics 2005 14 2209 2219 15987703
- [118]Ahmed SF The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation The Journal of biological chemistry 2012 287 15996 16006 22427670 PMC3346122
- [119]Gonzalez-Santamaria J Regulation of the tumor suppressor PTEN by SUMO Cell death & disease 2012 3 e393 23013792 PMC3461367
- [120]Herlevsen M A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer Biochemical and biophysical research communications 2007 352 549 555 17126809 PMC1933505
- [121]Freeman DJ PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms Cancer cell 2003 3 117 130 12620407
- [122]Zhou M PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells Cancer research 2003 63 6357 6362 14559824
- [123]Meuillet EJ Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity Archives of biochemistry and biophysics 2004 429 123 133 15313215
Cited by
Sorted by citations
Functions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232 · see citing works
Epidemiology of Glioblastoma Multiforme–Literature Review
Grochans, S., Cybulska, A. M., Simińska, D., Korbecki, J., Kojder, K., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · Cancers · doi:10.3390/cancers14102412 · Cited by 662 · see citing works
“The PI3K/Akt pathway is blocked by PTEN, and loss of functional PTEN impairs the regulation of cell survival, cell growth, and proliferation [84].”
PTEN: Multiple Functions in Human Malignant Tumors
Milella, M., Falcone, I., Conciatori, F., Incani, U. C., Curatolo, A. D., Inzerilli, N., Nuzzo, C. M. A., Vaccaro, V., Vari, S., Cognetti, F., et al. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00024 · Cited by 469 · see citing works
“PTEN-Long is expressed in normal tissues such as the breast and brain, whereas its expression levels are lower in human breast tumors and mouse models of glioblastoma (7, 20, 118).”
BackgroundHaddadi, N., Lin, Y., Travis, G., Simpson, A. M., Nassif, N. T., & McGowan, E. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0803-3 · Cited by 314 · see citing works
“null prostate cancer cells (PC-3) [138] induced apoptosis and regression of PTEN-null xenograft tumors in mice [139].”
Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer
Hopkins, B. D., Goncalves, M. D., & Cantley, L. C. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0329-9 · Cited by 288 · see citing works
Self-citationCurrent treatment strategies for inhibiting mTOR in cancer.
Chiarini, F., Evangelisti, C., McCubrey, J., & Martelli, A. (2015) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.004 · Cited by 262 · see citing works
Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
Biserova, K., Jakovļevs, A., Uljanovs, R., & Štrumfa, I. (2021) · Cells · doi:10.3390/cells10030621 · Cited by 224 · see citing works
PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
Lee, M., Jeong, M., Lee, H.-W., Han, H.-J., Ko, A., Hewitt, S., Kim, J.-H., Chun, K.-H., Chung, J., Lee, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms8769 · Cited by 176 · see citing works
The PI3K/Akt/PTEN/mTOR Pathway: A Fruitful Target for Inducing Cell Death in Rheumatoid Arthritis?
Malemud, C. J. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.55 · Cited by 174 · see citing works
Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system
Wang, C., Xue, Y., Markovic, T., Li, H., Wang, S., Zhong, Y., Du, S., Zhang, Y., Hou, X., Yu, Y., et al. (2025) · Nature Materials · doi:10.1038/s41563-024-02114-5 · Cited by 171 · see citing works
Self-citationCurrent clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer
Lim, H.-J., Crowe, P., & Yang, J.-L. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1803-3 · Cited by 161 · see citing works
“Subsequently, activated Akt transduces antiapoptotic signals by phosphorylating and inactivating key proteins involved in cell proliferation and survival, such as BAD, caspase-9, and forkhead (FoxO1/3a) transcription factors (Hopkins et al. 2014).”
BackgroundKobayashi, M., & Zochodne, D. W. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12833 · Cited by 160 · see citing works
Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications
Akter, S., Madhuvilakku, R., Kar, A. K., Nila, I. S., Liu, P., Inuzuka, H., Wei, W., & Hong, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02583-x · Cited by 119 · see citing works
PTEN in Autism and Neurodevelopmental Disorders.Preprint
Rademacher, S., & Eickholt, B. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036780 · Cited by 106 · see citing works
“Apart from its canonical lipid phosphatase function, PTEN is important for other cellular processes using its protein phosphatase activity in a compartment-specific fashion (Hopkins et al. 2014; Kreis et al. 2014).”
BackgroundPTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Serra, H., Chivite, Í., Angulo‐Urarte, A., Soler, A., Sutherland, J. D., Arruabarrena-Aristorena, A., Ragab, A., Lim, R., Malumbres, M., Fruttiger, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8935 · Cited by 109 · see citing works
Zheng, L., Liang, H., Zhang, Q., Shen, Z., Sun, Y., Zhao, X., Gong, J., Hou, Z., Jiang, K., Wang, Q., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01495-y · Cited by 147 · see citing works
“Beyond tumor suppression, PTEN has a key role in a variety of biological processes, including cell metabolism, cell motility, genome maintenance and cellular senescence [1].”
BackgroundInfluentialPalliyaguru, D. L., Chartoumpekis, D., Wakabayashi, N., Skoko, J., Yagishita, Y., Singh, S. V., & Kensler, T. (2016) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2016.10.003 · Cited by 96 · see citing works
“From the standpoint of cancer and tumorigenesis, Pten silencing plays a detrimental role as seen with prenatal death of Pten-knockout mice and the observation that more than 2700 PTEN mutations have been seen in 28 types of human tumors [68].”
Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance
Usman, S., Jamal, A., Teh, M., & Waseem, A. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2020.603160 · Cited by 91 · see citing works
“The PTEN protein behaves as a tumor suppressor through the action of its phosphatase protein product to dephosphorylate phosphatidylinositol-trisphosphate (PIP3) to PIP2 [113].”
BackgroundThe functions of tumor suppressor PTEN in innate and adaptive immunity
Chen, L., & Guo, D.-Y. (2017) · Cellular &Molecular Immunology · doi:10.1038/cmi.2017.30 · Cited by 91 · see citing works
Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury
Yang, C.-F. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_33_18 · Cited by 100 · see citing works
“PTEN, which was first identified as a tumor suppressor gene, is an essential regulator of cell proliferation, differentiation, growth, and apoptosis [90].”
BackgroundPTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting
Ciuffreda, L., Falcone, I., Incani, U. C., Curatolo, A. D., Conciatori, F., Matteoni, S., Vari, S., Vaccaro, V., Cognetti, F., & Milella, M. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.07.002 · Cited by 83 · see citing works
The HER2 Signaling Network in Breast Cancer—Like a Spider in its Web
Dittrich, A.-L., Gautrey, H., Browell, D., & Tyson-Capper, A. J. (2014) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-014-9329-5 · Cited by 81 · see citing works
“Negative regulators of this interaction are the phosphatase and tensin homolog (PTEN) [reviewed in [85]] and inositol polyphosphate 4phosphatase type II (INPP4B) which de-phosphorylates PIP3 to PIP2 and then to PIP [reviewed in [83]].”
Rexin, D., Meyer, C., Robaglia, C., & Veit, B. E. (2015) · Biochemical Journal · doi:10.1042/bj20150505 · Cited by 84 · see citing works
Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy
Ahmad, S., Bhatia, K., Kannan, A., & Gangwani, L. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s33122 · Cited by 78 · see citing works
Xu, W.-T., Yang, Z., Xie, C., Zhu, Y., Shu, X., Zhang, Z., Li, N.-S., Chai, N., Zhang, S., Wu, K.-C., et al. (2018) · Journal of experimental & clinical cancer research : CR · doi:10.1186/s13046-018-0795-2 · Cited by 75 · see citing works
NEDD4: A Promising Target for Cancer Therapy
Ye, X., Wang, L., Shang, B.-X., Wang, Z.-W., & Wei, W.-Y. (2014) · Current Cancer Drug Targets · doi:10.2174/1568009614666140725092430 · Cited by 75 · see citing works
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
Turnham, D. J., Bullock, N., Dass, M. S., Staffurth, J. N., & Pearson, H. B. (2020) · Cells · doi:10.3390/cells9112342 · Cited by 81 · see citing works
“Although PTEN is frequently lost through genomic alterations, post-transcriptional acetylation, ubiquitination and phosphorylation of PTEN have also been shown to impair PTEN stabilization, localization and/or phosphatase activity, while a number of regulatory proteins have also been shown to interact with PTEN at var…”
BackgroundProtein monoubiquitylation: targets and diverse functions
Nakagawa, T., & Nakayama, K. (2015) · Genes to Cells · doi:10.1111/gtc.12250 · Cited by 69 · see citing works
“PTEN thus antagonizes AKT-dependent cellular activities such as survival, growth and proliferation (Hopkins et al. 2014).”
BackgroundPTEN Inhibition in Human Disease Therapy
Pulido, R. (2018) · Molecules · doi:10.3390/molecules23020285 · Cited by 76 · see citing works
“Regulation of PTEN expression levels, protein conformation, and subcellular localization, is achieved by a variety of genetic, epigenetic, postranscriptional, and postranslational mechanisms affecting PTEN gene, mRNA, and protein [1,2,22].”
BackgroundMeng, Q.-L., Du, X.-Z., Wang, H., Gu, H.-M., Zhan, J.-P., & Zhou, Z.-P. (2017) · Apoptosis · doi:10.1007/s10495-017-1387-x · Cited by 69 · see citing works
“Gene of phosphate and tension homology deleted on chromosome ten (PTEN) is considered an effective negative regulatory factor for PI3K/Akt signaling [24, 42].”
BackgroundPoint mutations of the mTOR-RHEB pathway in renal cell carcinoma
Ghosh, A. P., Marshall, C. B., Coric, T., Shim, E., Kirkman, R. L., Ballestas, M. E., Ikura, M., Bjornsti, M., & Sudarshan, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4963 · Cited by 77 · see citing works
“, the gene encoding the PI3K catalytic subunit p110α) [51] or deletion/inactivation of tumor suppressors, including PTEN (phosphatase and tensin homolog) [52] , LKB1 (liver kinase B1) [53], and the protein phosphatase PP2A, which dephosphorylates and inactivates AKT [54].”
BackgroundINPP4B is an oncogenic regulator in human colon cancer
Guo, S. T., Chi, M., Yang, R.-H., Guo, X., Zan, L., Wang, C.-Y., Xi, Y.-F., Jin, L., Croft, A., Tseng, H.-Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.361 · Cited by 68 · see citing works
Ge, X., Li, M.-D., Yin, J.-X., Shi, Z.-M., Fu, Y., Zhao, N.-W., Chen, H., Meng, L., Li, X., Hu, Z., et al. (2022) · Molecules and Cells · doi:10.1016/j.molcel.2022.01.029 · Cited by 67 · see citing works
Hensel, N., Rademacher, S., & Claus, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00198 · Cited by 69 · see citing works
“Therefore, it is possible that beneficial effects of ROCK-inhibition in EAE are not only based on inhibition of neuroinflammation but are also mediated neuron-intrinsically.”
BackgroundPTEN arginine methylation by PRMT6 suppresses PI3K–AKT signaling and modulates pre-mRNA splicing
Feng, J., Dang, Y., Zhang, W., Zhao, X., Zhang, C., Hou, Z., Jin, Y., McNutt, M. A., Marks, A. R., & Yin, Y. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811028116 · Cited by 82 · see citing works
Elkholi, R., Renault, T. T., Serasinghe, M. N., & Chipuk, J. E. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-16 · Cited by 73 · see citing works
Chen, Y., Wang, T.-T., Du, J., Li, Y.-C., Wang, X., Zhou, Y., Yu, X., Fan, W., Zhu, Q., Tong, X.-M., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490142 · Cited by 61 · see citing works
Gu, P., Sun, M., Li, L., Yang, Y., Jiang, Z., Ge, Y., Wang, W., Mu, W., & Wang, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.657158 · Cited by 63 · see citing works
MicroRNA-26b modulates the NF-κB pathway in alveolar macrophages by regulating PTEN
Zhang, L., Huang, C.-Q., Guo, Y., Gou, X., Hinsdale, M. E., Lloyd, P. G., & Liu, L. (2015) · Journal of Immunology · doi:10.4049/jimmunol.1402933 · Cited by 57 · see citing works
“stream signaling (11), leading to increased cell proliferation and”
BackgroundDoghish, A., Hegazy, M., Ismail, A., El-Mahdy, H. A., Elsakka, E. G. E., Elkhawaga, S. Y., Elkady, M. A., Yehia, A. M., Abdelmaksoud, N. M., & Mokhtar, M. (2023) · Pathology, Research and Practice · doi:10.1016/j.prp.2023.154442 · Cited by 56
Zhou, Z., Tu, Z., Zhang, J., Tan, C., Shen, X., Wan, B.-B., Li, Y., Wang, A., Zhao, L.-Q., Hu, J.-J., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02714-1 · Cited by 56 · see citing works
“The genetic changes in PTEN lead to disorders of protein synthesis, DNA repair, and survival signals [16].”
BackgroundComprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
Serebriiskii, I. G., Pavlov, V., Tricarico, R., Andrianov, G., Nicolas, E., Parker, M. I., Newberg, J., Frampton, G., Meyer, J. E., & Golemis, E. A. (2022) · Nature Communications · doi:10.1038/s41467-022-29227-2 · Cited by 55 · see citing works
RGS12 Represses Oral Cancer via the Phosphorylation and SUMOylation of PTEN
Fu, C.-Y., Yuan, G.-S., Yang, S.-Y., Zhang, D., & Yang, S. (2020) · Journal of dentistry research · doi:10.1177/0022034520972095 · Cited by 54
“3A) and found that PTEN possesses a C-terminal 4 amino acid binding motif (ITKV) that can be recognized by a specific set of PDZ domains of some regulatory proteins (Hopkins et al. 2014).”
BackgroundPTEN: A yin-yang master regulator protein in health and disease
Pulido, R. (2015) · Methods · doi:10.1016/j.ymeth.2015.02.009 · Cited by 58 · see citing works
Redox Regulation of PTEN by Peroxiredoxins
Huu, T. N., Park, J., Zhang, Y., Park, I., Yoon, H., Woo, H., & Lee, S.-R. (2021) · Antioxidants · doi:10.3390/antiox10020302 · Cited by 51 · see citing works
“The C2 domain (amino acids 186-351) can bind phospholipid membrane independent of calcium because it lacks the canonical Ca2+ chelating residues in vitro, which makes PTEN inhibit cell migration [31].”
BackgroundThe emerging roles of the polycistronic miR-106b∼25 cluster in cancer – A comprehensive review
Mehlich, D., Garbicz, F., & Wlodarski, P. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.097 · Cited by 64 · see citing works
Bhattacharya, S., Mahato, R. K., Singh, S., Bhatti, G. K., Mastana, S., & Bhatti, J. S. (2023) · Life Science · doi:10.1016/j.lfs.2023.122110 · Cited by 48 · see citing works
Wang, Y., Liu, Y., Du, X., Ma, H., & Yao, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s241632 · Cited by 47 · see citing works
RetractedConjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma
Rossi, E., Schinzari, G., Maiorano, B., Pagliara, M., Stefani, A. D., Bria, E., Peris, K., Blasi, M., & Tortora, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215447 · Cited by 47 · see citing works
“The nuclear PTEN plays an oncosuppressive role [90,91]; it is abrogated in neoplastic cells by nuclear-cytoplasmic shuttling.”
BackgroundZhu, L.-L., Mou, Q.-J., Wang, Y., Zhu, Z., & Cheng, M. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4748 · Cited by 44 · see citing works
The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy
Szostak, J., Gorący, A., Durys, D., Dec, P., Modrzejewski, A., & Pawlik, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076214 · Cited by 46 · see citing works
“In addition to dephosphorylation of phosphatidylinositol (3,4,5)-triphosphate (PIP3), it is a vital negative regulator of the proto-oncogenic phosphatidylinositol 3-kinase (PI3K)–protein kinase B (Akt) and mammalian target of rapamycin (mTOR) pathways [65].”
BackgroundFeng, Y.-B., Hua, X., Niu, R., Du, Y., Shi, C.-J., Zhou, R.-P., & Chen, F.-H. (2019) · Biological Research · doi:10.1186/s40659-019-0232-9 · Cited by 43
Flavonoid-Based Cancer Therapy: An Updated Review.
Hosseinzadeh, E., Hassanzadeh, A., Marofi, F., Alivand, M., & Solali, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200423071759 · Cited by 42 · see citing works
Perspectives on the role of PTEN in diabetic nephropathy: an update
Khokhar, M., Roy, D., Modi, A., Agarwal, R. G., Yadav, D., Purohit, P., & Sharma, P. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1746735 · Cited by 41 · see citing works
Fu, L., Zhu, P., Qi, S., Li, C.-Y., & Zhao, K. (2018) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2018.08.040 · Cited by 42 · see citing works
PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma
Khalid, A., Hussain, T., Manzoor, S., Saalim, M., & Khaliq, S. (2017) · Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · doi:10.1177/1010428317705754 · Cited by 42 · see citing works
Zhang, Y.-Q., Liang, Y.-K., Wu, Y., Chen, M., Chen, W.-L., Li, R., Zeng, Y.-Z., Huang, W.-H., Wu, J.-D., Zeng, D., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03735-3 · Cited by 41 · see citing works
Fang, F., Li, Z.-L., Yu, J., Long, Y., Zhao, Q., Ding, X.-F., Wu, L., Shao, S.-M., Zhang, L., & Xiang, W.-P. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.01.003 · Cited by 41 · see citing works
“Both MYC and PETN genes are involved in numerous biological functions, like the regulation of cell cycle, proliferation, growth and differentiation [49,50].”
BackgroundDual-specificity phosphatases in mental and neurological disorders
An, N., Bassil, K. C., Jowf, G. I. A., Steinbusch, H. W. M., Rothermel, M., de Nijs, L., & Rutten, B. P. F. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101906 · Cited by 44 · see citing works
“The active catalytic site is HCxxGxxR (adapted from review (Hopkins et al., 2014; Worby and Dixon, 2014)).”
BackgroundNOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells
Zhu, L.-Q., Li, L.-L., Zhang, Q.-B., Yang, X., Zou, Z.-W., Hao, B.-T., Marincola, F., Liu, Z.-J., Zhong, Z., Wang, M., et al. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.11 · Cited by 40 · see citing works
Chen, Y., Yu, H., Zhu, D., Liu, P., Yin, J., Liu, D., Zheng, M., Gao, J., Zhang, C., & Gao, Y. (2020) · The FASEB Journal · doi:10.1096/fj.201902463rr · Cited by 42 · see citing works
Regulation of the tumor suppressor PTEN by natural anticancer compounds
Kim, D.-H., Suh, J., Surh, Y., & Na, H. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13422 · Cited by 39 · see citing works
Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
Saiki, Y., Jiang, C., Ohmuraya, M., & Furukawa, T. (2021) · Cancers · doi:10.3390/cancers14010071 · Cited by 38 · see citing works
“Furthermore, they develop benign tumors in various organs and cancers of the thyroid, prostate, or breast [55].”
BackgroundHuan, J., Grivas, P. D., Birch, J., & Hansel, D. E. (2022) · Cancers · doi:10.3390/cancers14061555 · Cited by 43 · see citing works
“Phosphatase and tensin homolog (PTEN), a tumor suppressor critical in mTOR pathway signaling [36], can function to dephosphorylate PIP3 at this stage, essentially turning “off” the cell signaling cascade prior to activation of mTOR.”
BackgroundLai, X., Wei, J., Gu, X.-Z., Yao, X.-M., Zhang, D.-S., Li, F., & Sun, Y.-Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16478 · Cited by 37 · see citing works
Ding, Z., Ogata, D., Roszik, J., Qin, Y., Kim, S.-H., Tetzlaff, M., Lazar, A., Davies, M., Ekmekcioglu, S., & Grimm, E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.631766 · Cited by 37
Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy
García‐Aranda, M., & Redondo, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092296 · Cited by 43 · see citing works
“PT EN PTEN This dual-specificity protein and lipid phosphatase blocks PI3K signaling by inhibiting PI3P-dependent processes such as AKT membrane recruitment and activation [108], which results in the inhibition of cell proliferation and survival [43].”
BackgroundSALL Proteins; Common and Antagonistic Roles in Cancer
Álvarez, C., Quiroz, A., Benítez-Riquelme, D., Riffo, E., Castro, A. F., & Pincheira, R. (2021) · Cancers · doi:10.3390/cancers13246292 · Cited by 37 · see citing works
“One of the central mechanisms is the inhibition of PTEN, a phosphatase that blocks the PI3K signaling pathway, inhibiting cell migration, proliferation, and survival [52].”
BackgroundFeng, Y., An, Q., Zhao, Z., Wu, M., Yang, C., Liang, W., Xu, X., Jiang, T., & Zhang, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116266 · Cited by 41 · see citing works
Wang, C., Wang, S., Ma, F., & Zhang, W.-D. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9478 · Cited by 36 · see citing works
“PTEN serves its tumor suppressor role by negatively regulating the phosphatidylinositol 3‑kinase (PI3K)‑RAC‑ α serine/threonine‑protein kinase (AKT) signaling pathway (15).”
Structure, Activity and Function of the Protein Arginine Methyltransferase 6
Gupta, S., Kadumuri, R. V., Singh, A., Chavali, S., & Dhayalan, A. (2021) · Life · doi:10.3390/life11090951 · Cited by 35 · see citing works
“PTEN negatively regulates AKT signaling by dephosphorylating the phosphatidylinositol-3,4,5-trisphosphate (PIP3) [145,146].”
BackgroundMolecular landscape of Hereditary Melanoma
Arnaut, J. R. M. B., Guimarães, I. D. S., dos Santos, A. C. E., da Silva, F. D. M. L., Machado, J. R. D. S., & de Melo, A. C. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103425 · Cited by 41 · see citing works
Wen, X., Li, H.-Y., Sun, H., Zeng, A., Lin, R., Zhao, J., & Zhang, Z.-Q. (2020) · Life Science · doi:10.1016/j.lfs.2020.117718 · Cited by 35
Circulating microRNAs in human obesity: a systematic review
Ortiz-Dosal, A., Rodil-García, P., & Salazar‐Olivo, L. A. (2019) · Biomarkers · doi:10.1080/1354750x.2019.1606279 · Cited by 44 · see citing works
“As an example, PTEN is a tumour suppressor gene; the loss of function in this gene is associated with the constitutive activation of Akt and the increased risk of breast, thyroid, uterine, and other types of cancer (Hopkins et al. 2014).”
BackgroundSun, J., Yan, J.-Q., Yuan, X.-Z., Yang, R., Dan, T.-Y., Wang, X.-S., Kong, G.-Q., & Gao, S.-G. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0022-0 · Cited by 34 · see citing works
“These crucial molecules involved in signaling pathways represent attractive targets for cancer therapy [54 – 57].”
BackgroundGene-based mediation analysis in epigenetic studies
Fang, R.-L., Yang, H.-T., Gao, Y.-Z., Cao, H.-Y., Goode, E., & Cui, Y.-H. (2020) · Briefings Bioinform. · doi:10.1093/bib/bbaa113 · Cited by 32 · see citing works
“This gene has been identified as a PTEN-binding protein [53] and attenuates PTEN functions by binding to PTEN, which is a potent tumor suppressor gene.”
BackgroundWang, X.-H., Pang, L., Zhang, Y.-Q., Xu, J., Ding, D., Yang, T., Zhao, Q.-M., Wu, F., Li, F., Meng, H.-W., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2499-6 · Cited by 32 · see citing works
“The AKT/mTOR signaling pathway is crucial for cell survival [11].”
BackgroundMarkowski, M., Marzo, A. D. D., & Antonarakis, E. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1393518 · Cited by 32 · see citing works
“conversion of phosphatidylinositol-(3,4,5]-trisphosphate (PIP3) to phosphatidylinositol-(4,5)-bisphosphonate (PIP2) [38].”
TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway
Yu, X., Li, S.-L., Pang, M., Du, Y., Xu, T., Bai, T., Yang, K., Hu, J.-C., Zhu, S., Wang, L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.613869 · Cited by 31 · see citing works
Steinbach, N., Hasson, D., Mathur, D., Stratikopoulos, E., Sachidanandam, R., Bernstein, E., & Parsons, R. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz272 · Cited by 31 · see citing works
“To reveal novel functions of nuclear PTEN, we performed a yeast-2-hybrid (Y2H) screen using the PTEN C2TAILdomain, which is thought to facilitate most of PTEN’s known interactions with other proteins (43), as the baitfragment against a library of prey-fragments of the human fetal brain.”
MethodSelf-citationYu, W.-C., Li, D.-W., Ding, X., Sun, Y., Liu, Y., Cong, J.-P., Yang, J., Sun, J., Ning, X.-C., Wang, H., et al. (2019) · Aging · doi:10.18632/aging.101846 · Cited by 31
“com 1481 AGING approach to predict the target genes for miR-510a, and putatively identified PTEN, a tumor suppressor gene that is frequently mutated/deleted in cancers after the p53 and Rb genes [26].”
BackgroundJohnston, S. B., & Raines, R. T. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00028 · Cited by 31 · see citing works
PTEN Hamartoma Tumor Syndrome and Immune Dysregulation
Eissing, M., Ripken, L., Schreibelt, G., Westdorp, H., Ligtenberg, M., Netea-Maier, R., Netea, M., de Vries, I. D., & Hoogerbrugge, N. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.11.003 · Cited by 30 · see citing works
Miyata, H., Ashizawa, T., Iizuka, A., Kondou, R., Nonomura, C., Sugino, T., Urakami, K., Asai, A., Hayashi, N., Mitsuya, K., et al. (2017) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20021 · Cited by 30
Dilmaghani, N. A., Safaroghli‐Azar, A., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2021) · IUBMB Life · doi:10.1002/iub.2446 · Cited by 30 · see citing works
“31).(57) Although it may be involved in a wide spectrum of cellular functions, PTEN intelligently blocks the PI3K/Akt signaling axis by depleting the cell reservoir from PIP3.”
BackgroundRegulatory non-coding RNAs in nervous system development and disease.
Oe, S., Kimura, T., & Yamada, H. (2019) · Frontiers in Bioscience · doi:10.2741/4776 · Cited by 29
“PTEN is a well-characterized tumor suppressor that is frequently mutated in various cancers (167).”
BackgroundZhu, C., Zhu, Q., Wu, Z., Yin, Y., Kang, D., Lu, S., & Liu, P. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25968 · Cited by 29 · see citing works
Xu, S.-Q., Qin, Y., Pan, D.-B., Ye, G.-X., Wu, C.-J., Wang, S., Jiang, J.-Y., Fu, J., & Wang, C.-J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4771 · Cited by 29
Wang, S., Liu, J. C., Kim, D., Datti, A., & Zacksenhaus, E. (2016) · Breast Cancer Research · doi:10.1186/s13058-015-0668-y · Cited by 29 · see citing works
“The latter is a phosphatase that converts phosphatidylinositol (3, 4, 5)-trisphosphate (PIP3) into phosphatidylinositol (4, 5)-disphosphate (PIP2), thereby antagonizing phoshotidylinositol-3 kinase (PI3K) pathway activation [6–8].”
BackgroundTenen, C. C., & Greenwald, I. (2019) · Current Biology · doi:10.1016/j.cub.2019.01.076 · Cited by 28 · see citing works
Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia
Miyashita, A., Kobayashi, M., Yokota, T., & Zochodne, D. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065977 · Cited by 29 · see citing works
Perdoncin, M., Konrad, A., Wyner, J. R., Lohana, S., Pillai, S. S., Pereira, D. G., Lakhani, H. V., & Sodhi, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.756499 · Cited by 38 · see citing works
Vidotto, T., Tiezzi, D., & Squire, J. (2018) · Molecular Cytogenetics · doi:10.1186/s13039-017-0348-y · Cited by 27 · see citing works
Xie, C.-Y., Kong, J., Zhao, C., Xiao, Y.-C., Peng, T., Liu, Y., & Wang, W.-N. (2016) · Developmental and Comparative Immunology · doi:10.1016/j.dci.2016.01.004 · Cited by 27
Jandy, M., Noor, A., Nelson, P. A., Dennys, C. N., Karabinas, I. M., Pestoni, J. C., Singh, G. D., Luc, L., Devyldere, R., Perdomo, N., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102247 · Cited by 26 · see citing works
“Interestingly, we also observed the activation of PTEN, an inhibitor of the PI3K/Akt pathway that acts through the dephosphorylation of phosphatidylinositol (3,4,5)-triphosphate (PIP3) to phosphatidylinositol (4,5)-bi-phosphate (PIP2) [54].”
BackgroundTargeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines.
Lim, H.-J., Wang, X., Crowe, P., Goldstein, D., & Yang, J.-L. (2016) · Anticancer Research · doi:10.21873/anticanres.11160 · Cited by 26 · see citing works
Wang, Y., Chen, B.-Y., Wang, Z., Zhang, W., Hao, K., Chen, Y., Li, K.-Q., Wang, T.-T., Xie, Y.-W., Huang, Z., et al. (2016) · OncoTarget · doi:10.18632/oncotarget.12654 · Cited by 26 · see citing works
“How does MTE promote the apoptosis of Jurkat cells? Since several studies have reported that phosphatases and tensin homolog (PTEN) is an essential tumor suppressor gene which encodes a phosphatase protein that antagonizes the PI3K/AKT/mTOR antiapoptotic pathway [12, 13], we next examined whether MTE promoted the apop…”
BackgroundNuclear PTEN’s Functions in Suppressing Tumorigenesis: Implications for Rare Cancers
Langdon, C. G. (2023) · Biomolecules · doi:10.3390/biom13020259 · Cited by 26 · see citing works
“Disrupting these PDZ-BD and PDZ interactions may lead to dysregulated subcellular localization as seen with MAST2 (microtubule associated serine/threonine kinase 2), PTEN, and the rabies viral glycoprotein or with MAGI-1b, -2, or -3 (membrane-associated guanylate kinase) scaffolding proteins and PTEN [54,64].”
Distinguishing between PTEN clinical phenotypes through mutation analysis
Portelli, S., Barr, L. J., de Sá, A. G. C., Pires, D. E. V., & Ascher, D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.028 · Cited by 25 · see citing works
“PTEN activity is closely regulated by its subcellular localization, which is mediated by post-translational modifications (PTMs) including phosphorylation, SUMOylation and ubiquitination, as well as protein–protein interactions [1,2].”
BackgroundThe role of PTEN - HCV core interaction in hepatitis C virus replication
Wu, Q., Li, Z.-B., Mellor, P., Zhou, Y., Anderson, D. H., & Liu, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-03052-w · Cited by 25 · see citing works
- Authors
- Hopkins, B. D., Hodakoski, C., Barrows, D., Mense, S. M., & Parsons, R. E.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Parsons, Ramon E.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 39
- Issue
- 4
- Pages
- 183-190
- ISSN
- 0968-0004 (ISSN-L)
- PMC
- PMC4043120
- OpenAlex
- W2109559424
- Cited by
- 309
- References
- 125
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 29 · 2023: 21 · 2022: 24 · 2021: 35 · 2020: 36 · 2019: 32 · 2018: 22 · 2017: 22 · 2016: 13 · 2015: 25 · 2014: 11
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Biochemical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01CA097403, R01CA082783, R01CA155117, R01CA184016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homolog, tumor suppressor, phosphatase activity, protein-protein interaction, post-translational modification, protein stability, cancer, cell cycle regulation, DNA repair, cell migration
- MeSH terms
- Animals, Cell Cycle, Gene Expression Regulation, Humans, Protein Processing, Post-Translational, Genomic Instability, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review